We are live on ! Find out more
AMN icon

AMN Healthcare

248 hedge funds and large institutions have $809M invested in AMN Healthcare in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 98 increasing their positions, 84 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 84

2% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $3.89M

3.04% less ownership

Funds ownership: 105.2%102.16% (-3%)

15% less funds holding

Funds holding: 292248 (-44)

18% less capital invested

Capital invested by funds: $983M → $809M (-$174M)

61% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 69

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
248
Holders Change
-44
Holders Change %
-15.07%
% of All Funds
3.27%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
27
Increased
98
Reduced
84
Closed
69
Calls
$3.82M
Puts
$3.89M
Net Calls
-$72K
Net Calls Change
-$658K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$125M -$3.93M -189,056 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$90.4M +$36.8K +1,770 +0%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$49.4M +$21.8M +1,047,550 +78%
State Street
4
State Street
Massachusetts
$33.3M +$81.9K +3,939 +0.2%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$19.1M -$901K -43,331 -4%
Bank of America
6
Bank of America
North Carolina
$19M +$1.99M +95,720 +12%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$18.8M +$627K +30,155 +3%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$17.5M -$2.86M -137,567 -14%
Charles Schwab
9
Charles Schwab
California
$17.2M -$1.5M -72,240 -8%
Morgan Stanley
10
Morgan Stanley
New York
$17.1M -$808K -38,862 -4%
Federated Hermes
11
Federated Hermes
Pennsylvania
$13.5M +$10.2M +491,454 +307%
Barclays
12
Barclays
United Kingdom
$13.3M +$5.49M +264,242 +70%
CP
13
CenterBook Partners
Connecticut
$13.2M +$10.1M +488,029 +321%
Two Sigma Investments
14
Two Sigma Investments
New York
$12.7M +$2.67M +128,523 +26%
Allianz Asset Management
15
Allianz Asset Management
Germany
$11.9M +$2.18M +104,676 +22%
UBS Group
16
UBS Group
Switzerland
$11.5M +$44.3K +2,129 +0.4%
NSCM
17
New South Capital Management
Tennessee
$11.2M -$738K -35,490 -6%
Goldman Sachs
18
Goldman Sachs
New York
$10.9M +$2.06M +99,167 +23%
AG
19
Algert Global
California
$10.8M +$3.33M +159,959 +44%
TCM
20
Tributary Capital Management
Nebraska
$8.99M -$1.16M -55,700 -11%
Renaissance Technologies
21
Renaissance Technologies
New York
$8.89M -$948K -45,610 -10%
Northern Trust
22
Northern Trust
Illinois
$8.89M -$471K -22,654 -5%
Pacer Advisors
23
Pacer Advisors
Pennsylvania
$8.09M -$1.92M -92,442 -19%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$7.66M +$4.8M +231,079 +166%
Invesco
25
Invesco
Georgia
$7.38M +$178K +8,582 +2%

AMN Hedge Fund Activity: Q2 2025 in Review

248 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AMN Healthcare (AMN) for Q2 2025, worth a combined $809M — down 18% from $983M a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of AMN and 27 opened new positions — a net loss of 42 holders — while 84 trimmed existing stakes and 98 added.

The largest buyer was Fidelity Investments, adding an estimated $21.8M. The largest seller was Newtyn Management, cutting an estimated $19M.

  • 248 institutional investors held AMN Healthcare (AMN) as of Q2 2025, down from 292 in Q1 2025.
  • Funds reported $809M of AMN Healthcare stock for Q2 2025, down 18% quarter-over-quarter.
  • 27 funds opened new AMN Healthcare positions in Q2 2025 and 69 closed out, a net change of -42 holders.
  • The largest AMN Healthcare buyer in Q2 2025 was Fidelity Investments, an estimated $21.8M added.
  • The largest AMN Healthcare seller in Q2 2025 was Newtyn Management, an estimated $19M sold.

Based on aggregated 13F filings for Q2 2025.